GREPPI, MARCO
 Distribuzione geografica
Continente #
EU - Europa 3.547
AS - Asia 591
NA - Nord America 461
SA - Sud America 46
AF - Africa 15
OC - Oceania 2
Totale 4.662
Nazione #
IT - Italia 3.428
US - Stati Uniti d'America 435
SG - Singapore 190
CN - Cina 152
VN - Vietnam 127
BD - Bangladesh 68
BR - Brasile 36
FR - Francia 35
HK - Hong Kong 24
FI - Finlandia 20
CA - Canada 17
GB - Regno Unito 16
DE - Germania 15
JP - Giappone 7
TR - Turchia 6
MX - Messico 5
ES - Italia 4
AR - Argentina 3
CH - Svizzera 3
ID - Indonesia 3
IN - India 3
IQ - Iraq 3
NL - Olanda 3
TN - Tunisia 3
UA - Ucraina 3
ZA - Sudafrica 3
AU - Australia 2
BG - Bulgaria 2
CL - Cile 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
ET - Etiopia 2
KR - Corea 2
MA - Marocco 2
MD - Moldavia 2
MK - Macedonia 2
PK - Pakistan 2
SI - Slovenia 2
AL - Albania 1
BE - Belgio 1
BO - Bolivia 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
KE - Kenya 1
LT - Lituania 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
PY - Paraguay 1
RO - Romania 1
RU - Federazione Russa 1
SE - Svezia 1
SO - Somalia 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
ZM - Zambia 1
Totale 4.662
Città #
Genoa 1.490
Genova 1.130
Vado Ligure 338
Rapallo 299
San Jose 150
Singapore 90
Ashburn 55
Ho Chi Minh City 40
Milan 40
Hanoi 37
Beijing 33
New York 28
Lauterbourg 25
Los Angeles 24
Hong Kong 22
Council Bluffs 19
Helsinki 19
Santa Clara 16
Valenza 13
Bordighera 12
Frankfurt am Main 11
Catania 8
Rome 8
Da Nang 6
Tokyo 6
Buffalo 5
Chicago 5
Haiphong 5
Messina 5
Orem 5
Boardman 4
Charlotte 4
City of London 4
London 4
Piscataway 4
Basingstoke 3
Brescia 3
Cambridge 3
Cardiff 3
Chieti 3
Dallas 3
Hanover 3
Johannesburg 3
Marseille 3
Minneapolis 3
Montreal 3
Naples 3
Phoenix 3
Rovereto 3
Toronto 3
Addis Ababa 2
Ankara 2
Baghdad 2
Barcelona 2
Bologna 2
Calgary 2
Curitiba 2
Grezzana 2
Hưng Yên 2
Ljubljana 2
Maringá 2
Mexico City 2
Padua 2
Paris 2
Prague 2
Queens 2
Skopje 2
Sydney 2
São José do Rio Preto 2
São Paulo 2
Tianjin 2
Abadia de Goiás 1
Acalanes Ridge 1
Agadir 1
Albuquerque 1
Alexandria 1
Algiers 1
Amsterdam 1
Ancona 1
Apple Valley 1
Arequipa 1
Arzano 1
Ascurra 1
Athens 1
Atlanta 1
Avella 1
Bahía Blanca 1
Balsas 1
Baltimore 1
Bandung 1
Belleville 1
Belmont 1
Bensalem 1
Biên Hòa 1
Borgomanero 1
Brussels 1
Caldas Novas 1
Can Tho 1
Cappelle sul Tavo 1
Casablanca 1
Totale 4.080
Nome #
Different features of tumor-associated NK cells in patients with low-grade or high-grade peritoneal carcinomatosis 247
New miRNA signature heralds human NK cell subsets at different maturation steps: Involvement of miR-146a-5p in the regulation of KIR expression 231
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 222
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 178
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 177
Harnessing NK Cells for Cancer Treatment 174
PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells 154
Cancer immunotherapy by blocking immune checkpoints on innate lymphocytes 148
NK Cell-Based Immunotherapy in Colorectal Cancer 147
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 147
New miRNA signature heralds human NK cell subsets at different maturation steps: involvement of miR- 146a-5p in the regulation of KIR expression 143
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 143
New Insights into Endometrial Cancer 141
miRNAs in NK Cell-Based Immune Responses and Cancer Immunotherapy 139
NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advances 135
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 135
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancer 128
Role of the main non HLA-specific activating NK receptors in pancreatic, colorectal and gastric tumors surveillance 127
Harnessing Immune Response in Acute Myeloid Leukemia 126
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer 126
A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans 125
Expression, role and regulation of NK cell immune checkpoints (PD-1, KIRs, NKG2A) in Ovarian Cancer 125
Histopathological And Immunohistochemical Prognostic Factors In High-Grade Non-Endometrioid Carcinomas Of The Endometrium (Hg-Necs). Is It Possible To Identify Sub-Groups At Increased Risk? 109
The PD-1 immune checkpoint on human NK cells in normal and pathological condition 96
Case report: Variable response to immunotherapy in ovarian cancer: Our experience within the current state of the art 95
Identification of a novel cord blood NK cell subpopulation expressing functional programmed death receptor-1 94
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 94
PD-1+ NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immune-checkpoint blockade 93
A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans 82
Colorectal cancer-infiltrating NK cell landscape analysis unravels tissue-resident PD-1+ NK cells in microsatellite instability tumors 81
Standardized Photobiomodulation Dosimetry Targeting the Base of Calvarial Critical-Sized Defects for Bone Regeneration: A Preclinical RCT Comparing Flattop vs. Gaussian Beam Profiles, with or Without Bio-Oss® 80
The PD-1 immune checkpoint on human NK cells in normal and pathological condition 80
Case Report: A Peculiar Case of Inflammatory Colitis After SARS-CoV-2 Infection 72
Relevant role for PD-1 immune checkpoint expressed on NK cells derived from ovarian cancer patients 71
The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers 70
null 66
Relevant role for PD-1 immune checkpoint expressed on NK cells derived from ovarian cancer patients 56
Immunological Analysis of Oral Cytobrush Specimens for Early Detection of Oral Cancer Biomarkers: A Comprehensive Review 42
Case report: Non-invasive cyto-salivary sampling and biomarker detection via ELISA versus histopathology for diagnosing oral potentially malignant disorders - Insights from a case-control study 29
Tumor-Infiltrating Natural Killer Cells 27
Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancer 14
Partial Inhibition Of Nampt Restores Metabolic Vulnerability And Synergizes With Anti-Myeloma Agents In Multiple Myeloma 12
Totale 4.781
Categoria #
all - tutte 15.629
article - articoli 12.732
book - libri 0
conference - conferenze 1.979
curatela - curatele 0
other - altro 513
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.853


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 0 0 0 0 0 0 35
2021/2022298 9 9 17 23 28 26 16 61 38 27 17 27
2022/2023359 35 32 6 28 57 44 2 28 70 6 42 9
2023/2024349 13 36 9 43 22 35 33 58 16 21 26 37
2024/2025964 36 55 37 74 92 90 104 170 34 65 96 111
2025/20261.902 186 46 121 164 220 123 235 94 176 204 161 172
Totale 4.781